Chloroquine-resistant Plasmodium vivax in Papua New Guinea
- 1 March 1992
- journal article
- case report
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 86 (2) , 121-122
- https://doi.org/10.1016/0035-9203(92)90531-g
Abstract
An Australian expatriate on regular weekly antimalarial prophylaxis with chloroquine base and Maloprim developed symptomatic Plasmodium vivax infection which failed to respond adequately to 600 mg of chloroquine base. More ominously, a resident of the Highlands region of Papua New Guinea contracted vivax malaria which failed to be cleared by 2400 mg chloroquine base administered over 4 d. Both patients had achieved appropriate blood and plasma concentrations of chloroquine after treatment. Chloroquine-resistant P. vivax is now a clinical fact in Papua New Guinea.Keywords
This publication has 5 references indexed in Scilit:
- Chloroquine-ResistantPlasmodium vivaxfrom IndonesiaNew England Journal of Medicine, 1991
- CHLOROQUINE-RESISTANT PLASMODIUM VIVAXThe Lancet, 1989
- PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?The Lancet, 1989
- A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case reportTransactions of the Royal Society of Tropical Medicine and Hygiene, 1989
- Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982